We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$7.68B
AUM Growth
+$3.22B
Cap. Flow
+$3.51B
Cap. Flow %
45.78%
Top 10 Hldgs %
77.12%
Holding
65
New
7
Increased
1
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
NEUE
NeueHealth
NEUE
+$3.74B
2
GLUE icon
Monte Rosa Therapeutics
GLUE
+$157M
3
BILL icon
BILL Holdings
BILL
+$87.9M
4
CVRX icon
CVRx
CVRX
+$66.4M
5
OKUR
OnKure Therapeutics
OKUR
+$53.4M

Top Sells

Rank Stock Value
1
COUR icon
Coursera
COUR
+$196M
2
DM
Desktop Metal, Inc.
DM
+$118M
3
SPT icon
Sprout Social
SPT
+$89.2M
4
EAR
Eargo, Inc. Common Stock
EAR
+$83.8M
5
OPEN icon
Opendoor
OPEN
+$59.2M

Sector Composition

Rank Sector Weight
1 Healthcare 79.9%
2 Consumer Staples 8.56%
3 Technology 5.15%
4 Industrials 3.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRTX
26
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$42.9M 0.56%
4,362,986
– –
BDTX icon
27
Black Diamond Therapeutics
BDTX
$113M
$42.1M 0.55%
3,449,845
– –
INZY
28
DELISTED
Inozyme Pharma
INZY
$41.7M 0.54%
2,444,379
– –
SVRA icon
29
Savara
SVRA
$1.08B
$41M 0.53%
24,137,931
– –
AFMD
30
DELISTED
Affimed
AFMD
$37.6M 0.49%
442,649
-97,877
-18% -$8.93M
UPST icon
31
Upstart Holdings
UPST
$2.46B
$35.9M 0.47%
287,092
-286,092
-50% -$35.2M
BE icon
32
Bloom Energy
BE
$76.4B
$35.8M 0.47%
1,333,333
– –
VRNA
33
DELISTED
Verona Pharma
VRNA
$33.4M 0.44%
5,108,563
– –
ELVN icon
34
Enliven Therapeutics
ELVN
$3.91B
$31.7M 0.41%
1,004,293
– –
MRKR icon
35
Marker Therapeutics
MRKR
$19.5M
$29.9M 0.39%
1,071,429
– –
AVEO
36
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$26.1M 0.34%
3,952,958
– –
PHAS
37
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$24.7M 0.32%
6,643,704
– –
LITS
38
Lite Strategy Inc
LITS
$37.1M
$24.3M 0.32%
426,654
– –
GNCA
39
DELISTED
Genocea Biosciences, Inc.
GNCA
$24.3M 0.32%
10,376,936
– –
STSA
40
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$22.2M 0.29%
3,142,958
+145,276
+5% +$783K
CBIO
41
Crescent Biopharma
CBIO
$698M
$21.1M 0.27%
90,890
– –
GERN icon
42
Geron
GERN
$842M
$19M 0.25%
13,461,538
– –
XENE icon
43
Xenon Pharmaceuticals
XENE
$5.45B
$18.5M 0.24%
992,107
– –
CTIC
44
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$17.9M 0.23%
7,140,450
– –
CSBR icon
45
Champions Oncology
CSBR
$66.4M
$17.6M 0.23%
1,713,720
– –
ADXN
46
Addex Therapeutics
ADXN
$4.13M
$17.2M 0.22%
+9,000
New +$1.83M
SYBX
47
DELISTED
Synlogic
SYBX
$16.5M 0.21%
281,961
– –
IVA
48
Inventiva
IVA
$912M
$14.2M 0.19%
1,041,666
– –
OBSV
49
DELISTED
ObsEva SA Ordinary Shares
OBSV
$13.9M 0.18%
4,586,563
– –
TRVI icon
50
Trevi Therapeutics
TRVI
$2.14B
$13.4M 0.17%
5,940,796
– –
1
2
3

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q2 2021 Portfolio in Review

As of Q2 2021, NEA Management Company held 65 positions worth $7.68B, up 72% from $4.46B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

NEA Management Company deployed $3.51B of net new capital in Q2 2021, opening 7 new positions and adding to 1 existing holding. Its largest new stake was NeueHealth: 2,727,652 shares worth $3.74B.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 54% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Coursera, an estimated $196M trimmed.

  • NEA Management Company's largest Q2 2021 buy was NeueHealth: 2,727,652 shares worth $3.74B.
  • NEA Management Company added most to Satsuma Pharmaceuticals, Inc. Common Stock in Q2 2021, an estimated $783K increase.
  • NEA Management Company's biggest Q2 2021 reduction was Coursera, cutting an estimated $196M.
  • NEA Management Company fully exited Sprout Social in Q2 2021, selling an estimated $89.2M.
  • NEA Management Company's ten largest holdings make up 77% of its $7.68B portfolio in Q2 2021.
  • NEA Management Company opened 7 new positions and closed 2 in Q2 2021.
  • NEA Management Company's portfolio value rose 72% quarter-over-quarter to $7.68B.

Based on NEA Management Company's 13F filing for Q2 2021, filed 2 Aug 2021.